Orion Corporation will publish its financial result for 2007 on Thursday, 7 February 2008.
The publication dates of the Interim Reports in 2008 are as follows:
Interim Report 1-3/2008 Friday, 25 April 2008
Interim Report 1-6/2008 Tuesday, 5 August 2008
Interim Report 1-9/2008 Tuesday, 28 October 2008
Annual Report 2007 will be published during week 10/2008.
The Annual General Meeting is planned to be held on Tuesday, 25 March 2008, at 14.00 EET, in Helsinki.
Orion's financial reports and related presentation material are available on the Group's home pages at www.orion.fi/investors promptly after the publishing. The homepage also provides a possibility to register on Orion's mailing lists for publications and releases.
For additional information, kindly contact:
Susanna Siira, Investor Relations Manager, tel. +358 10 426 2782
Jari Karlson Olli Huotari
CFO SVP, Corporate Functions
OMX Nordic Exchange Helsinki
Orion is a European pharmaceutical and diagnostics company which emphasises the development of innovative medicinal treatments and diagnostic tests for global markets. Orion develops, manufactures and markets pharmaceuticals for humans and animals, active pharmaceutical ingredients as well as diagnostic tests. Orion's clientele consists mainly of healthcare service providers and professionals. The Group's net sales in 2006 (proforma) were EUR 641.1 million and in the end of 2006 there were 3 061 employees working for the Group. Orion's stocks are listed in OMX Nordic Exchange Helsinki. In 2007, Orion celebrates its 90-year-history.